This Cancer Drug Is So Effective, The FDA Approved It Immediately
June 11, 2017
A new cancer drug has overwhelmingly helped shrink or eradicate tumors in patients whose cancer had resisted every other form of treatment.
The results, published in the journal Science, are so striking that the Food and Drug Administration already has approved the drug.
Image credit: Merck
The study followed 86 cancer patients with tumors of the pancreas, prostate, uterus or bone. Each patient was given pembrolizumab, which also goes by the brand name Keytruda.
After taking the drug, 66 patients had their tumors shrink substantially and stabilize, instead of continuing to grow. Among them were 18 patients whose tumors vanished and have not returned.
According to the New York Times, this is the first time a drug has been approved for use against tumors that share a particular genetic profile, regardless of where they appear in the body.
Dr. Jack Jacoub, a medical oncologist and director of thoracic oncology at Memorial Care Cancer Institute at Orange Coast Memorial Medical Center, said "The FDA doesn't take these kinds of things lightly. The data was so good, they had to approve it."
Click Here For The Most Popular On Sunny Skyz
Starbucks Barista Breaks Down In Tears After Customer Returns With Note
Woman's Post Sparks A Flood Of Heartfelt Kindness Stories, And Tears Are Flowing Everywhere
Local Police Department Makes Public Statement To Community On Taylor Swift's New Album
Rainn Wilson Gets A 'The Office' Style Room Service Surprise On Vacation
Pawsitively Pampered: Park Ranger Gives Lions Foot Massages
Baby Boom: Kentucky Sheriff's Office Celebrates 15 Bundles Of Joy
Alligator Filmed Climbing In A Fence In South Carolina
Starbucks Barista Breaks Down In Tears After Customer Returns With Note
Roles Reversed: A Service Dog Asks For Help
Little Girl Does An Amazingly Realistic Lion Roar, Viewers Are In Disbelief
Incredible Footage: Train Conductor Finds Himself Caught In Tornado's Path